Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Margaret C. Cummings
PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Novel Highly Specific Anti-Periostin Antibodies Uncover the Functional Importance of the Fascilin 1-1 Domain and Highlight Preferential Expression of Periostin in Aggressive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology
Related publications
Bcl‐2 Inhibitors Enhance FGFR Inhibitor‐induced Mitochondrial‐dependent Cell Death in FGFR 2 Mutant Endometrial Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
Frontiers in Oncology
Cancer Research
Oncology
BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Antitumor Effect of FGFR Inhibitors on a Novel Cholangiocarcinoma Patient Derived Xenograft Mouse Model Endogenously Expressing an FGFR2-CCDC6 Fusion Protein
Cancer Letters
Cancer Research
Oncology
Effective Use of PI3K and MEK Inhibitors to Treat Mutant Kras G12D and PIK3CA H1047R Murine Lung Cancers
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
PARP Inhibitors: Extending Benefit Beyond BRCA Mutant Cancers
Clinical Cancer Research
Cancer Research
Oncology
Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates
Cancer Research
Cancer Research
Oncology
Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer
Science Translational Medicine
Medicine
